Archive for January, 2010
(AGNC) REIT Outlook & Stock Review – January 2010 – Industry Outlook
Real Estate Investment Trusts The U.S. Real Estate Investment Trust (REIT) industry registered a strong recovery and year-end performance in 2009. The FTSE NAREIT Equity REIT Index reported total returns of 27.99% in 2009, vs. a 26.46% and 18.82% gain for the S&P 500 and...
25Jan2010 | vitalstocks | 0 comments | Continued(WDC) Western Digital Corporation – Earnings Strongly Beat Forecasts
Western Digital Corp. (WDC) reported better than expected fourth-quarter results yesterday after the bell that easily beat analyst expectations. Fourth-Quarter Results Revenue was up 44% from last year to $2.62 billion. Earnings also came in strong at $1.85, 49 cents ahead of...
25Jan2010 | vitalstocks | 0 comments | Continued(JPM) JPMorgan Chase – Bear of the Day
We are downgrading our rating on JPMorgan Chase (JPM) shares to Underperform. Fourth quarter earnings were well ahead of the Zacks Consensus Estimate, aided by better-than-expected results at its Investment Bank segment. However, persistent high levels of consumer credit costs...
25Jan2010 | vitalstocks | 0 comments | Continued(PH) Parker Hannifin – Bull of the Day
We are upgrading the recommendation on Parker Hannifin (PH) to Outperform with a $67 target price. We are encouraged that order trends have improved sequentially for the prior two consecutive quarters, indicating that the worst is behind the company. Reflecting the benefits of...
25Jan2010 | vitalstocks | 0 comments | Continued(SBUX) Starbucks Corporation – Analysts Further Increase Estimates
Starbucks Corp. (SBUX) just crushed Wall Street’s expectation by setting record earnings. Starbucks just reported record quarterly earnings on Jan 20. The coffee giant saw net revenues rise 4% to $2.7 billion. The increase was on slightly higher traffic and higher average...
25Jan2010 | vitalstocks | 0 comments | Continued(GYMB) Gymboree Corporation – Earnings Surprised in Seven of Seven Quarters
Gymboree Corporation (GYMB) recently revised its earnings guidance for the fiscal fourth quarter which ends Jan 30. Earnings per share are now expected to be in the range of $1.03 to $1.06 which is higher than the prior guidance of 95 cents to $1.03. Gymboree attributes the rise...
25Jan2010 | vitalstocks | 0 comments | Continued(ED) Consolidated Edison Earnings Fall Behind Consensus
Consolidated Edison Inc. (ED) announced its fourth quarter results of fiscal 2009 with earnings per share (EPS) of 67 cents, which fell short of both the Zacks Consensus EPS Estimate of 77 cents and the year-ago EPS of 72 cents. EPS was affected by the dilutive effect of a higher...
23Jan2010 | vitalstocks | 0 comments | Continued(NTCT) NetScout Systems’ Third Quarter Report Meets Estimates
NetScout Systems Inc. (NTCT) reported fiscal 2010 third-quarter earnings on Thursday. The company posted GAAP earnings of $8.5 million, compared to $7.9 million in the year-ago period. Excluding certain special items, adjusted earnings per share came in at 23 cents, which matched...
23Jan2010 | vitalstocks | 0 comments | Continued(VIVO) Meridian Bioscience Misses Expectations by a Penny
Recently, Meridian Bioscience Inc. (VIVO) reported results for the first quarter of fiscal 2010. The company earned 22 cents per share in the quarter which fell short of the Zacks Consensus Estimate by a penny. Meridian Bioscience earned 20 cents per share in the year-ago quarter. Net...
23Jan2010 | vitalstocks | 0 comments | Continued(SLB) Schlumberger Limited’s Profit Dips But Tops Expectations
Schlumberger Limited (SLB) has reported its fourth-quarter and full-year 2009 results. Diluted earnings per share from continuing operations were 67 cents, compared to the Zacks Consensus Estimate of 63 cents and the year-earlier earnings of $1.03. Diluted earnings from continuing...
23Jan2010 | vitalstocks | 0 comments | Continued(IPG) Interpublic Group Unit Weber Shandwick Wins Contract
Weber Shandwick, a unit of Interpublic Group (IPG), was recently awarded an $866,000 contract by the Nevada Secretary of State’s Office. According to the contract, Weber Shandwick is supposed to implement a public outreach program designed to ensure a complete and accurate...
23Jan2010 | vitalstocks | 0 comments | Continued(GENZ) Genzyme Corporation Gets FDA Action Date for Lumizyme
Genzyme Corp. (GENZ) recently announced that the US Food and Drug Administration (FDA) has assigned an action date for the company’s Biologics License Application for Lumizyme (alglucosidase alfa) for the treatment of Pompe disease. Genzyme is seeking approval for Lumizyme...
23Jan2010 | vitalstocks | 0 comments | Continued(BBT) BB&T Corporation Beats Earnings Estimates
BB&T Corporation (BBT) reported fourth quarter operating earnings per share of 27 cents, substantially ahead of the Zacks Consensus Estimate of 20 cents and the reported figure of 23 cents in the prior quarter. However, earnings decreased from 51 cents in the year-ago quarter. During...
23Jan2010 | vitalstocks | 0 comments | Continued(WDC) Western Digital’s Earnings Strongly Beat Expectations
Western Digital (WDC) reported second quarter 2010 EPS of $1.85, exceeding the Zacks Consensus Estimate of $1.36. Revenue Western Digital reported first quarter 2010 revenue of $2.62 billion, up 43.9% from the prior year and 19.0% on a sequential basis. Revenue from sales of...
23Jan2010 | vitalstocks | 0 comments | Continued(CNXT) Conexant Tops Earnings Expectations
Conexant (CNXT) recently reported revenues of $61.8 million, up 10% year over year. Gross margin came in at 61%, up from 60.2% in the previous quarter and better than management’s expectation of 60%. Operating margin came in at 22%. Earnings per share came in at 17 cents beating...
23Jan2010 | vitalstocks | 0 comments | Continued(EXC) Exelon’s Earnings Results Top Estimates
Exelon Corporation (EXC) reported fourth-quarter and full-year 2009 earnings per share (EPS) of 92 cents and $4.12, respectively, above the Zacks Consensus Estimate of 85 cents and $4.04. However, it fell short of the year-ago figure of $1.07 for the fourth quarter of 2008 and...
23Jan2010 | vitalstocks | 0 comments | Continued(APD) Air Products and Chemicals’ Profits Improve
Atmospheric and industrial gas producer Air Products and Chemicals (APD) announced operating results for the first quarter of fiscal 2010. Earnings for the quarter were $1.16 per share, slightly higher than both the Zacks Consensus Estimate and the market estimate of $1.14, helped...
23Jan2010 | vitalstocks | 0 comments | Continued(HBAN) Huntington Bancshares Incorporated Misses Expectations – Loan Loss Provisions Rise
Huntington Bancshares Incorporated (HBAN) reported a fourth quarter loss of 56 cents per share. Excluding the impact of significant items, the company incurred a loss of 65 cents in the quarter. Results were well below the Zacks Consensus Estimate of a loss of 28 cents. However,...
23Jan2010 | vitalstocks | 0 comments | Continued(PBCT) People’s United Financial’s Earnings Meet Expectations
People’s United Financial, Inc.’s (PBCT) fourth quarter operating earnings per share of 8 cents were flat with the Zacks Consensus Estimate and third quarter earnings. However, earnings declined from 10 cents in the prior-year quarter due to continued market pressure, which...
23Jan2010 | vitalstocks | 0 comments | Continued(ARW) Arrow Electronics Expected to Outperform
We recently upgraded our rating on Arrow Electronics, Inc. (ARW) to OUTPERFORM from NEUTRAL. New York-based Arrow Electronics is one of the world’s largest distributors of electronic components and computing products. The company sources products from about 800 suppliers and...
23Jan2010 | vitalstocks | 0 comments | Continued(NRP) Natural Resource Partners L.P. Issues 2010 Earnings Guidance
Master limited partnership Natural Resource Partners L.P. (NRP) yesterday provided its production and earnings guidance for 2010. The partnership projects coal production in 2010 to be essentially flat, ranging from 41 to 50 million tons. The partnership guided total revenue...
23Jan2010 | vitalstocks | 0 comments | Continued(HOG) Harley-Davidson’s Earnings Miss Badly
Harley-Davidson (HOG) has reported a loss of $147.2 million or 63 cents per share in the fourth quarter of 2009, compared to an income of $91.9 million or 40 cents per share in the comparable period a year ago. Compared to the Zacks Consensus Estimate of a loss of 34 cents per...
23Jan2010 | vitalstocks | 0 comments | Continued(GHDX) Genomic Health Announces Commercial Availability Of Its Oncotype DX Colon Cancer Test
Recently, Genomic Health, Inc. (GHDX) announced the global commercial availability of its Oncotype DX colon cancer test. The 12-gene diagnostic test aims to predict individual recurrence risk in stage II colon cancer patients after surgery. The Genomic Health test is the first...
23Jan2010 | vitalstocks | 0 comments | Continued(GENZ) Genzyme Corporation’s Outlook Stabilizing
Genzyme Corp. (GENZ) reports fourth-quarter results on February 17, with the current Zacks Consensus Estimate at 20 cents per share. Recent revisions to the quarterly estimate have been in both directions, with a very modest upward (positive) bias. Of the 12 estimates for the...
23Jan2010 | vitalstocks | 0 comments | Continued(FRX) Forest Laboratories Announces Promising COPD Drug
Recently, Forest Laboratories (FRX) and Spain based Almirall announced positive phase III top-line results of Forest’s pipeline candidate aclidinium, a multi dose dry-powder inhaler for the treatment of chronic obstructive pulmonary disease (COPD). It was observed that aclidinium...
23Jan2010 | vitalstocks | 0 comments | Continued(CBST) Cubist Pharmaceuticals Misses Estimates
Cubist Pharmaceuticals (CBST) reported earnings per share (EPS) of 38 cents for the fourth quarter of 2009, missing the Zacks Consensus Estimate by 3 cents and down from $1.43 reported in the year-ago period. Last year’s results were inflated by a tax benefit of $100 million....
23Jan2010 | vitalstocks | 0 comments | Continued(ABAX) Abaxis Receives FDA Approval
Abaxis, Inc. (ABAX) recently received the U.S. Food and Drug Administration (FDA) approval to market its new C-Reactive Protein (CRP) assay in the United States. The new C-Reactive Protein assay is used by healthcare professionals in conjunction with Abaxis’ Piccolo Xpress...
23Jan2010 | vitalstocks | 0 comments | Continued(IFF) International Flavors & Fragrances Coverage Initiated as Neutral
International Flavors & Fragrances Inc. (IFF), the leading creator and manufacturer of flavor and fragrance compounds, was recently initiated as “Neutral.” The company regularly creates new compounds to meet the changing characteristics and composition of customers’...
23Jan2010 | vitalstocks | 0 comments | Continued(GCO) Genesco Incorporated – Earnings Reports Tops Estimates
Genesco Inc. (GCO) is trading at a great value but also has earnings momentum on analyst upgrades and a bullish outlook. Company Description Genesco sells footwear, headwear and other accessories in the U.S. and Canada. Products are branded under Journeys, Lids, Underground Station...
23Jan2010 | vitalstocks | 0 comments | Continued(ARW) Arrow Electronics – Bull of the Day
Arrow Electronics, Inc. (ARW) recently upgraded its outlook for the fourth quarter of 2009. The company now expects revenues to come between $3.8 billion and $4.2 billion in the December quarter, up from the previous guidance of $3.65 billion to $4.25 billion. Management stated...
23Jan2010 | vitalstocks | 0 comments | Continued